chevron_leftBack
As of 8 June 2026, AI Maverick Intel, Inc. has a market cap of $1.85M USD, ranking #47361 globally and #2484 in Canada.
It ranks #4202 in the Healthcare sector, and #885 in the Medical Devices industry.
Key Stats
Market Cap
$1.85MUSD
Revenue (TTM)
$92.26KUSD
EBITDA (TTM)
-$385.71KUSD
Net Income (TTM)
-$1.62MUSD
PS Ratio
52.4
PB Ratio
-4.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
Employees
5
Website
aimaverickintel.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -17% | -25% | -6.3% | 164% | 114% | -6.3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BINP
Bionoid Pharma Inc Ordinary Shares
ISIN: US09076D1019
Shares Out.:
Shares Outstanding:
48.756M1
Shares Float:
20.07M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0750 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About AI Maverick Intel, Inc.
AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, Inc. was incorporated in 2006 and is based in Beverly Hills, California.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: BLCO
|
$5.47B
295K%
|
-
|
|
TSX: EDT
|
$290.28M
16K%
404.92M CAD
|
-
|
|
TSX: PRN
|
$238.87M
13K%
333.22M CAD
|
-
|
|
TSXV: TLT
|
$64.23M
3K%
89.6M CAD
|
-
|
|
TSXV: COV
|
$37.42M
2K%
52.2M CAD
|
55.0
|
|
TSXV: PINK
|
$31.69M
2K%
44.2M CAD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
9M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
9M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
9M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
7M%
|
34.7
|
|
NYSE: SYK
|
$120.69B
7M%
|
38.3
|
|
NYSE: MDT
|
$101.9B
6M%
|
22.2
|
chevron_leftBack